[ITEM 5.02 DEPARTURE OF DIRECTORS OR CERTAIN OFFICERS; ELECTION OF DIRECTORS; APPOINTMENT OF CERTAIN OFFICERS;MPENSATORY ARRANGEMENTS OF CERTAIN OFFICERS. The purpose of the 2009 Stock Option Plan is to enhance the long-term stockholder value of thempany by offering opportunities to directors, officers, employees and eligiblensultants of thempany to acquire and maintain stock ownership in thempany]
[] [[MAPLES AND CALDER LETTERHEAD] Our ref AEO\628564\3415033v2 Direct +852 2971 3081 Email alice.ooi@maplesandcalder.com Wuxi PharmaTech (Cayman) Inc. 288 Fute Zhong Road Waigaoqiao Free Trade Zone Shanghai 200131 People Republic of China 4 September 2009 Dear Sir Wuxi PharmaTech (Cayman) Inc. Company Registration Statement Commission Act Prospectus ADSs Shares Unissued Shares We act as Cayman Islands counsel for Wuxi PharmaTech (Cayman)] [September 4, 2009 WuXi PharmaTech (Cayman) Inc. 288 Fute Zhong Road Waigaoqiao Free Trade Zone Shanghai 200131, PRC Re: American Depositary Shares Representing Ordinary Shares of WuXi PharmaTech (Cayman) Inc. Ladies and Gentlemen: September 4, 2009 - Page 2 The above opinion is provided to the Company for the Companys use in connection with the transactions that are the subject] [Commerce & Finance Law Offices 6F NCI Tower, A12 Jianguomenwai Avenue, Chaoyang District, Beijing, PRC; Postcode: 100022 Tel: (8610) 65693399 Fax: (8610) 65693838, 65693836, 65693837, 65693839 www.tongshang.com.cn E-mail Add: beijing@tongshang.com Website: September 4, 2009 WuXi PharmaTech (Cayman) Inc. 288 Fute Zhong Road Waigaoqiao Free Trade Zone Shanghai 200131 Peoples Republic of China Dear Sirs: For the purposes of giving this] [CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM We consent to the incorporation by reference in this Registration Statement on Form F-3 of our reports dated June 25, 2009, relating to the financial statements and financial statement schedule of WuXi PharmaTech (Cayman) Inc., and the effectiveness of WuXi PharmaTech (Cayman) Inc.s internal control over financial reporting, appearing in the Annual Report]
[] [[MAPLES AND CALDER LETTERHEAD] Our ref AEO\628564\3415033v2 Direct +852 2971 3081 Email alice.ooi@maplesandcalder.com Wuxi PharmaTech (Cayman) Inc. 288 Fute Zhong Road Waigaoqiao Free Trade Zone Shanghai 200131 People Republic of China 4 September 2009 Dear Sir Wuxi PharmaTech (Cayman) Inc. Company Registration Statement Commission Act Prospectus ADSs Shares Unissued Shares We act as Cayman Islands counsel for Wuxi PharmaTech (Cayman)] [September 4, 2009 WuXi PharmaTech (Cayman) Inc. 288 Fute Zhong Road Waigaoqiao Free Trade Zone Shanghai 200131, PRC Re: American Depositary Shares Representing Ordinary Shares of WuXi PharmaTech (Cayman) Inc. Ladies and Gentlemen: September 4, 2009 - Page 2 The above opinion is provided to the Company for the Companys use in connection with the transactions that are the subject] [Commerce & Finance Law Offices 6F NCI Tower, A12 Jianguomenwai Avenue, Chaoyang District, Beijing, PRC; Postcode: 100022 Tel: (8610) 65693399 Fax: (8610) 65693838, 65693836, 65693837, 65693839 www.tongshang.com.cn E-mail Add: beijing@tongshang.com Website: September 4, 2009 WuXi PharmaTech (Cayman) Inc. 288 Fute Zhong Road Waigaoqiao Free Trade Zone Shanghai 200131 Peoples Republic of China Dear Sirs: For the purposes of giving this] [CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM We consent to the incorporation by reference in this Registration Statement on Form F-3 of our reports dated June 25, 2009, relating to the financial statements and financial statement schedule of WuXi PharmaTech (Cayman) Inc., and the effectiveness of WuXi PharmaTech (Cayman) Inc.s internal control over financial reporting, appearing in the Annual Report]
[ITEM 5.02 DEPARTURE OF DIRECTORS OR CERTAIN OFFICERS; ELECTION OF DIRECTORS; APPOINTMENT OF CERTAIN OFFICERS;MPENSATORY ARRANGEMENTS OF CERTAIN OFFICERS. The purpose of the 2009 Stock Option Plan is to enhance the long-term stockholder value of thempany by offering opportunities to directors, officers, employees and eligiblensultants of thempany to acquire and maintain stock ownership in thempany]
[SCHEDULE 14C INFORMATION X] [ Preliminary Information Statement [] [ ] Definitive Information Statement CHINA PHARMA H OLDINGS, . Payment of Filing Fee (Check the appropriate box): [X] No fee required. [] Feemputed on table below per Exchange Act Rules 14c-5(g) and 0-11. 1) Title of each class of securities to which transaction applies:]
[SCHEDULE 14C INFORMATION X] [ Preliminary Information Statement [] [ ] Definitive Information Statement CHINA PHARMA H OLDINGS, . Payment of Filing Fee (Check the appropriate box): [X] No fee required. [] Feemputed on table below per Exchange Act Rules 14c-5(g) and 0-11. 1) Title of each class of securities to which transaction applies:]
[Skystar Bio-Pharmaceutical Awarded High Technology Enterprise Certificate Preferential Income Tax Rate Extended through 2011 XI'AN, CHINA, September 2, 2009 — Skystar Bio-Pharmaceutical Company High Technology Enterprise Certificates are awarded to qualified enterprises that meet the following criteria: developing core intellectual property rights, receiving over 60% of their annual revenues from high-technology products/services, and perform highly technical research and development. Skystar]
[Skystar Bio-Pharmaceutical Awarded High Technology Enterprise Certificate Preferential Income Tax Rate Extended through 2011 XI'AN, CHINA, September 2, 2009 — Skystar Bio-Pharmaceutical Company High Technology Enterprise Certificates are awarded to qualified enterprises that meet the following criteria: developing core intellectual property rights, receiving over 60% of their annual revenues from high-technology products/services, and perform highly technical research and development. Skystar]
